1. Augmented apoptotic efficacy of brentuximab vedotin combined with lenalidomide in CD-30 expressing Sézary syndrome cell lines. (2019) Authors: Bakou, V.; Spathis, Aris; Bouhla, Anthi; Glezou, Eirini; Stavroulaki, Georgia; Thomopoulos, T.; Gkontopoulos, Konstantinos; Pappa, V.; Papadavid, E. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗